Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving this market. On the basis of geographical analysis, the North American region is expected to retain its dominance in this market owing to better healthcare infrastructure, high healthcare expenditure on urological disorders, increased awareness in the society increasing the outpatients center and hospitals visits.
This report elaborates on the current development of the Benign Prostatic Hyperplasia industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Merck
Eli Lilly
Allergan
Astellas Pharma
GlaxoSmithKline
Mylan
Novartis
Pfizer
Abbott
Sanofi
TEVA
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Drug Therapy
Dialysis
Other
Application:
Hospitals
Clinics
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Benign Prostatic Hyperplasia Industry Overview
-
1.1.1 Benign Prostatic Hyperplasia Market Scope and Market Segments
-
1.1.2 Benign Prostatic Hyperplasia Industry Characteristics
-
1.1.3 Global and China Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Benign Prostatic Hyperplasia Production Value and Growth Rate (2017-2028)
-
1.2 Global Benign Prostatic Hyperplasia Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Drug Therapy
-
1.2.2 Dialysis
-
1.2.3 Other
-
1.3 Global Benign Prostatic Hyperplasia Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Clinics
-
1.4 Market Analysis by Region
-
1.4.1 North America Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Benign Prostatic Hyperplasia Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Benign Prostatic Hyperplasia Industry Porter's Five Forces Model Analysis
-
2.2.3 Benign Prostatic Hyperplasia Industry PEST Analysis
-
2.3 Benign Prostatic Hyperplasia Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Benign Prostatic Hyperplasia Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Benign Prostatic Hyperplasia Industry
Chapter 3 Global and China Benign Prostatic Hyperplasia Market, by Manufacturer
-
3.1 Global and China Benign Prostatic Hyperplasia Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Benign Prostatic Hyperplasia Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Benign Prostatic Hyperplasia Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Benign Prostatic Hyperplasia Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Benign Prostatic Hyperplasia Market Top 3 Players
Chapter 4 Global and China Benign Prostatic Hyperplasia Market, by Type (2017-2028)
-
4.1 Benign Prostatic Hyperplasia Market Trend, by Type
-
4.2 Global Benign Prostatic Hyperplasia Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Benign Prostatic Hyperplasia Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Benign Prostatic Hyperplasia Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Benign Prostatic Hyperplasia Price Trend, by Type (2017-2028)
-
4.3 China Benign Prostatic Hyperplasia Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Benign Prostatic Hyperplasia Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Benign Prostatic Hyperplasia Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Benign Prostatic Hyperplasia Price Trend, by Type (2017-2028)
Chapter 5 Global and China Benign Prostatic Hyperplasia Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Benign Prostatic Hyperplasia Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Benign Prostatic Hyperplasia Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Benign Prostatic Hyperplasia Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Benign Prostatic Hyperplasia Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Benign Prostatic Hyperplasia Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Benign Prostatic Hyperplasia Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Benign Prostatic Hyperplasia Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Benign Prostatic Hyperplasia Market Analysis
-
7.1 North America Benign Prostatic Hyperplasia Market, by Type
-
7.2 North America Benign Prostatic Hyperplasia Market, by Application
-
7.3 North America Benign Prostatic Hyperplasia Market Analysis and Forecast, by Country
-
7.3.1 United States Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Benign Prostatic Hyperplasia Market Analysis
-
8.1 Europe Benign Prostatic Hyperplasia Market, by Type
-
8.2 Europe Benign Prostatic Hyperplasia Market, by Application
-
8.3 Europe Benign Prostatic Hyperplasia Market Analysis and Forecast, by Country
-
8.3.1 Germany Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Benign Prostatic Hyperplasia Market Analysis
-
9.1 APAC Benign Prostatic Hyperplasia Market, by Type
-
9.2 APAC Benign Prostatic Hyperplasia Market, by Application
-
9.3 APAC Benign Prostatic Hyperplasia Market Analysis and Forecast, by Country
-
9.3.1 China Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Market Analysis
-
10.1 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Market, by Type
-
10.2 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Market, by Application
-
10.3 Latin America, Middle East and Africa Benign Prostatic Hyperplasia Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Benign Prostatic Hyperplasia Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Benign Prostatic Hyperplasia Company Profiles
-
11.1 Merck
-
11.1.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Merck Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.1.3 Merck Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Eli Lilly Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.2.3 Eli Lilly Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Allergan
-
11.3.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Allergan Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.3.3 Allergan Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Astellas Pharma
-
11.4.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Astellas Pharma Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.4.3 Astellas Pharma Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 GlaxoSmithKline
-
11.5.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 GlaxoSmithKline Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.5.3 GlaxoSmithKline Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Mylan
-
11.6.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Mylan Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.6.3 Mylan Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Novartis
-
11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Novartis Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.7.3 Novartis Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Pfizer
-
11.8.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Pfizer Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.8.3 Pfizer Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Abbott
-
11.9.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Abbott Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.9.3 Abbott Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Sanofi
-
11.10.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Sanofi Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.10.3 Sanofi Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 TEVA
-
11.11.1 TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 TEVA Benign Prostatic Hyperplasia Product Profiles, Application and Specification
-
11.11.3 TEVA Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Benign Prostatic Hyperplasia Industry Investment Prospect and Risk Assessment
-
12.1 Benign Prostatic Hyperplasia Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Benign Prostatic Hyperplasia Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Production Value and Growth Rate (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Production Value and Growth Rate (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate of Drug Therapy (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate of Dialysis (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate of Clinics (2017-2028)
-
Figure North America Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Benign Prostatic Hyperplasia Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Benign Prostatic Hyperplasia Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Benign Prostatic Hyperplasia Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Benign Prostatic Hyperplasia Market Share, by Manufacturer in 2021
-
Figure Global and China Benign Prostatic Hyperplasia Market Share, by Manufacturer in 2022
-
Table Global Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Value, by Type (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Value Share, by Type (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Price Trend, by Type (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Value, by Type (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Value Share, by Type (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Price Trend, by Type (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Value, by Application (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Sales Value Share, by Application (2017-2028)
-
Figure Global Benign Prostatic Hyperplasia Sales Value Share, by Application (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Value, by Application (2017-2028)
-
Table China Benign Prostatic Hyperplasia Sales Value Share, by Application (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Value Share, by Application (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
Figure North America Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Benign Prostatic Hyperplasia Production, Import, Consumption and Export (2017-2022)
-
Table North America Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table North America Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure North America Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table North America Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table North America Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure North America Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure United States Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure United States Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Canada Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Table Europe Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table Europe Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure Europe Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table Europe Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table Europe Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure Europe Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure Germany Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure UK Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure UK Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure France Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure France Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Italy Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Spain Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Poland Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Russia Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Table APAC Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table APAC Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure APAC Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table APAC Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table APAC Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure APAC Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure China Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Japan Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure India Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure India Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Benign Prostatic Hyperplasia Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Benign Prostatic Hyperplasia Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Benign Prostatic Hyperplasia Sales Value and Growth Rate (2017-2028)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan Product Profiles, Application and Specification
-
Table Allergan Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Astellas Pharma Product Profiles, Application and Specification
-
Table Astellas Pharma Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Product Profiles, Application and Specification
-
Table Mylan Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbott Product Profiles, Application and Specification
-
Table Abbott Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TEVA Product Profiles, Application and Specification
-
Table TEVA Benign Prostatic Hyperplasia Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
